Cheng et al. (2014) reported that transplantation of Ngn2-transduced mesenchymal stem cells (MSCs) decreased apoptotic cells and improved neurological functional recovery by increasing the expression of BDNF against stroke. Here, NEUROG2 is linked to stroke disorder.